Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli

Authors


  • Editor: Ian Henderson

Correspondence: Victoria Korolik, Microbial Glycobiology, Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Qld, Australia, 4215. Tel.: +61 7 5552 8321; fax: +61 7 5552 8908; e-mail: v.korolik@griffith.edu.au

Abstract

Campylobacter jejuni and Campylobacter coli are recognized as the most common causative agents of bacterial gastroenteritis in the world and infections with these organisms occur more frequently than do infections due to Salmonella species, Shigella species, or Escherichia coli 0157:H7. The incidence of human Campylobacter infections has increased markedly in both developed and developing countries worldwide and, more significantly, so has the rapid emergence of antibiotic-resistant Campylobacter strains, with evidence suggesting that the use of antibiotics, in particular the fluoroquinolones, as growth promoters in food animals and the veterinary industry is accelerating this trend. In this minireview, the patterns of emerging resistance to the antimicrobial agents useful in treatment of the disease are presented and the mechanisms of resistance to these drugs in Campylobacter spp are discussed.

Ancillary